ADCYAP1 and focal segmental glomerulosclerosis: As our observations in humans showed more pronounced PACAP deficiency and increased platelet counts in CNS compared to INS [9], we decided to use a CNS animal model rather than a model mimicking minimal change nephrotic syndrome (MCNS) or focal segmental glomerulosclerosis (FSGS).